- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01617499
Physical Activity for Campus Employees (PACE)
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Cardiovascular disease (CVD) persists as the leading cause of mortality in the United States and accounts for 17 percent of the nation's overall health expenditures. Although the mortality rate of CVD has declined in recent years, the burden of disease remains high. Currently, 1 in 3 Americans has some form of CVD. Additionally, according to a recent policy statement published by the American Heart Association (AHA), 40% of the population is projected to have some form of CVD by 2030. Furthermore, the AHA has projected that the cost to treat CVD will triple by 2030. The prevalence and rising financial burden of CVD demonstrate the urgency for effective implementation of disease prevention strategies.
Evidence suggesting the majority of CVD is preventable through modifiable risk factor management continues to grow. Nonetheless, difficulty controlling modifiable risk factors remains an issue for many Americans. The magnitude of this challenge is supported by a study revealing that 78% of adults are candidates for at least one CVD prevention activity. Although national organizations have published a variety of disease prevention recommendations, widespread implementation of and adherence to preventative programs remain problematic. Consequently, a large proportion of the population is not receiving or participating in prevention strategies from which they may benefit. The full potential of reducing the nation's CVD burden cannot be achieved unless interventions are implemented on a larger scale, with reduced costs, and with increased initial and continued participation.
With approximately 130 million Americans currently employed, workplaces provide ideal environments for implementation of sizable, cost-effective CVD prevention programs. However, successful wellness programming remains a laborious, resource intensive challenge for employers. In 2004, a National Worksite Health Promotion Survey disclosed that less than 7% of U.S. employers offered worksite wellness programs. Furthermore, an estimated 25-30% of companies' annual medical costs are spent on employees with CVD risk factors.
In the proposed study, a worksite wellness program that includes health assessments, personal health reports, and pedometer-based tracking of physical activity will be offered to university employees. Participants will not be randomized to an intervention or control group. Rather, program components will be available to all enrolled participants, and each individual may choose whether to wear a pedometer, track their step counts, attend wellness sessions, and/or complete the health assessments. There is no prescribed intervention. Wellness sessions include educational information on lifestyle behaviors to promote cardiometabolic health.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
Missouri
-
St. Louis, Missouri, Spojené státy, 63108
- Washington University
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- employee of Washington University in St. Louis
Exclusion Criteria:
- pregnancy
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
University employees
Participants will include employees of Washington University in St. Louis.
Recruitment will be directed to staff employees of the Central Fiscal Unit (CFU) on the Danforth campus.
|
The worksite wellness program included cardiovascular health assessments, personal health reports, 8 weeks of pedometer-based walking and tracking activities, and weekly wellness sessions.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Daily Step Count (determined by pedometer)
Časové okno: Baseline, week 4, and week 8
|
Daily step counts, as recorded by pedometers, will be self-reported by participants for 7 continuous days at 3 study time points: baseline, week 4, and week 8.
|
Baseline, week 4, and week 8
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Body weight
Časové okno: Baseline and week 9
|
Body weight will be measured on a digital scale in the morning after an overnight fast.
Shoes, jewelry, sweaters, jackets, belts, and hats will be removed and pockets will be emptied before the measurement is made.
|
Baseline and week 9
|
|
Body Mass Index (BMI)
Časové okno: Baseline and week 9
|
BMI will be computed as weight in kilograms divided by height in meters squared.
Weight Status will be determined using standard CDC BMI categories.
|
Baseline and week 9
|
|
Body Composition
Časové okno: Baseline and week 9
|
Fat mass (kg), fat free mass (kg), and percentage body fat will be determined by bioelectrical impedance analysis using the InBody 520 analyzer.
|
Baseline and week 9
|
|
waist circumference
Časové okno: Baseline and week 9
|
Waist circumference will be measured at the border of the iliac crest using a Gulick II tape measure.
|
Baseline and week 9
|
|
Blood Pressure
Časové okno: Baseline and week 9
|
Systolic and diastolic blood pressure will be measured in duplicate in the right arm after 10 minutes of seated rest using the Omron HEM-907XL Professional Digital Blood Pressure Monitors (Omron Healthcare, Kyoto, Japan).
One minute rest will be provided between the 2 measurements.
|
Baseline and week 9
|
|
Fasting plasma glucose
Časové okno: Baseline and week 9
|
Fasting plasma glucose will be measured from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
Total Cholesterol
Časové okno: Baseline and week 9
|
Total cholesterol will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
LDL Cholesterol
Časové okno: Baseline and week 9
|
LDL cholesterol will be computed using the Friedewald equation from the lipid profile measured from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
HDL Cholesterol
Časové okno: Baseline and week 9
|
HDL cholesterol will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
Triglycerides
Časové okno: Baseline and week 9
|
Triglycerides will be quantified from a fingerstick blood sample in the morning after an overnight fast using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
Non-HDL Cholesterol
Časové okno: Baseline and week 9
|
Non-HDL cholesterol will be computed by difference based on the lipid profile determined from a fasted fingerstick blood sample using the Cholestech LDX System® (Hayward, CA).
|
Baseline and week 9
|
|
Resting heart rate
Časové okno: Baseline and week 9
|
Resting heart rate will be measured in duplicate in the morning after 10 minutes of seated rest using Omron HEM-907XL Professional Digital Blood Pressure Monitors (Omron Healthcare, Kyoto, Japan).
|
Baseline and week 9
|
|
Cardiorespiratory fitness based on post-exercise recovery heart rate
Časové okno: Baseline and week 9
|
Cardiorespiratory fitness will be estimated based on heart rate recovery following a 3-minute step test performed with an 8-inch step and a metronome set to 96 beats/minute.
Participants will be instructed to maintain the pace set by the beat of the metronome for 3 consecutive minutes and to be seated immediately at the completion of the 3-minute test.
The subject's right radial pulse rate will be measured for 30 seconds, beginning 30 seconds after the completion of the test.
Cardiorespiratory fitness level will be computed based on sex- and age-specific heart rate criteria.
|
Baseline and week 9
|
|
Dietary patterns
Časové okno: Baseline and week 9
|
Dietary patterns will be assessed using the nutrition questions from the CDC Behavioral Risk Factor Surveillance System (BRFSS).
|
Baseline and week 9
|
|
Physical activity patterns
Časové okno: Baseline and week 9
|
Physical activity patterns will be assessed using the exercise questions from the CDC Behavioral Risk Factor Surveillance System (BRFSS).
|
Baseline and week 9
|
|
Perceived barriers to exercise participation
Časové okno: Baseline and week 9
|
Perceived barriers to exercise participation will be assessed using the "Exercise Barriers" questionnaire, which the subject will complete on his/her own.
|
Baseline and week 9
|
|
Perceived benefits of exercise
Časové okno: Baseline and week 9
|
Perceived benefits of exercise will be assessed using the "Exercise Benefits" questionnaire, which the subject will complete on his/her own.
|
Baseline and week 9
|
|
Participant evaluation of the wellness program
Časové okno: Weeks 12 - 14
|
Participants will be asked to provide feedback about the wellness program through a 10-question, anonymous, online survey administered using the web-based Survey Monkey tool.
|
Weeks 12 - 14
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Susan B Racette, PhD, Washington University School of Medicine
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 201109022
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Physical activity
-
Ming-Yuan ChihDokončeno
-
Centre Hospitalier Universitaire de BesanconNáborJuvenilní idiopatická artritidaFrancie
-
University of Health Sciences LahoreAktivní, ne nábor
-
The First Affiliated Hospital of Guangzhou Medical...Neznámý
-
Northeastern UniversitySociety for Pediatric Psychology; APA: American Psychological AssociationNáborPorucha autistického spektra (ASD)Spojené státy
-
The University of Hong KongNáborDemence | Zátěž pečovatele | Kognitivní porucha, mírná | Demence, mírnáHongkong
-
Istanbul Kültür UniversityMarmara University; Istanbul University - Cerrahpasa (IUC)DokončenoFyzická aktivita | Parkinsonova choroba | Zůstatek | Padající | KineziofobieKrocan
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Roche Diagnostics GmbHNáborKardiomyopatie | Genetická predispozice | Kardiomyopatie, primárníSpojené království
-
University of Alabama at BirminghamCenters for Disease Control and PreventionDokončenoRodinné vztahy | PlíseňSpojené státy